250 Participants Needed

Biobehavioral Intervention for Testicular Cancer

MA
Overseen ByMichael A Hoyt, PhD
Age: 18 - 65
Sex: Male
Trial Phase: Academic
Sponsor: University of California, Irvine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Listening (ISL) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1), twelve weeks after intervention (T2) and 24 weeks after the intervention (T3). Additionally, identified biomarkers will be measured at baseline and at T1, T2, and T3.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Goal-Focused Emotion-Regulation Therapy (GET) for testicular cancer?

Research shows that GET can help young adult testicular cancer survivors by reducing stress-related markers in the body and improving emotional regulation and goal-setting skills, which are important for managing the psychological impact of cancer.12345

Is Goal-Focused Emotion-Regulation Therapy (GET) safe for humans?

GET has been studied in young adult testicular cancer survivors and showed potential to reduce stress-related processes and inflammation without significant adverse effects reported. More research is needed to confirm its safety and effectiveness.12345

How is the treatment Goal-Focused Emotion-Regulation Therapy (GET) unique for testicular cancer survivors?

Goal-Focused Emotion-Regulation Therapy (GET) is unique because it specifically targets the emotional and goal-related challenges faced by young adult testicular cancer survivors, aiming to improve distress symptoms and emotion regulation while also addressing stress-sensitive biomarkers, which is not commonly the focus of other treatments for this condition.12346

Research Team

MA

Michael A Hoyt, PhD

Principal Investigator

University of California, Irvine

Eligibility Criteria

This trial is for young adults aged 18-39 who have had testicular cancer and finished chemotherapy within the last 4 years. They must be fluent in English or Spanish, feel distressed (scoring >4 on a Distress Thermometer), and be able to consent. It's not for regular smokers, those with immune-affecting conditions, recent heart attacks or strokes, Type I diabetes, acute hepatitis, recent vaccinations, or a history of psychiatric or cognitive disturbances.

Inclusion Criteria

Able to perform informed consent
English fluency, as per medical record documenting preferred language or in the judgment of the investigator
Spanish fluency, as per medical record documenting preferred language or in the judgment of the investigator
See 3 more

Exclusion Criteria

I am unable to understand or complete the study requirements.
You smoke cigarettes every day.
I do not have immune-related conditions that could affect the study.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive six sessions of Goal-focused Emotion-Regulation Therapy (GET) or Individual Supportive Listening (ISL) over eight weeks

8 weeks
6 sessions (virtual)

Follow-up

Participants are monitored for psychological and biobehavioral outcomes post-treatment

24 weeks
Assessments at 3-month and 6-month post-intervention

Treatment Details

Interventions

  • Goal-Focused Emotion-Regulation Therapy (GET)
  • Individual Supportive Listening
Trial Overview The study tests Goal-focused Emotion-Regulation Therapy (GET) against Individual Supportive Listening (ISL) to see if GET can better improve emotional distress symptoms and skills like emotion regulation and goal setting in testicular cancer survivors. Participants will get six sessions over eight weeks with follow-up assessments up to six months after the therapy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Goal-Focused Emotion-Regulation Therapy (GET)Experimental Treatment1 Intervention
A novel behavioral intervention to enhance self-regulation through improved goal navigation skills, improved sense of purpose, and better ability to regulate emotional responses in young adults with testicular cancer.
Group II: Individual Supportive ListeningActive Control1 Intervention
Supportive therapy will be non-directive and will primarily reinforce a patient's ability to manage stressors through attentively listening and encouraging expression of thoughts and feelings, assisting the individual to gain a greater understanding of their situation and alternatives, and helping to buttress the individual's self-esteem and resilience.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Irvine

Lead Sponsor

Trials
580
Recruited
4,943,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Memorial Sloan Kettering Cancer Center

Collaborator

Trials
1,998
Recruited
602,000+

Findings from Research

A novel intervention called Goal-focused Emotion-Regulation Therapy (GET) was found to be feasible and acceptable for young adult testicular cancer survivors, with positive feedback on its helpfulness and satisfaction from participants.
The intervention led to clinically meaningful improvements in symptoms of depression and anxiety, suggesting it could effectively support emotional well-being and goal navigation in this population.
Goal-focused Emotion-Regulation Therapy for young adult survivors of testicular cancer: Feasibility of a behavioral intervention.Hoyt, MA., Nelson, CJ.[2021]
Goal-focused Emotion-regulation Therapy (GET) was found to be a feasible and acceptable intervention for young adult testicular cancer survivors, with 81.1% of participants completing all sessions, indicating high engagement.
Participants in the GET group experienced greater reductions in anxiety and depressive symptoms compared to those receiving Individual Supportive Listening (ISL), with medium effect sizes suggesting meaningful improvements in mental health outcomes.
Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study.Hoyt, MA., Wang, AW., Ceja, RC., et al.[2023]
A randomized controlled trial is being conducted to evaluate Goal-focused Emotion-Regulation Therapy (GET) for young adult testicular cancer survivors, aiming to improve psychological distress and emotional regulation over 8 weeks with six therapy sessions.
The study will assess the feasibility of GET and its impact on depressive and anxiety symptoms, as well as stress-sensitive biomarkers, highlighting the need for targeted interventions to support young cancer survivors in managing their emotional and life goals.
Goal-Focused Emotion-Regulation Therapy (GET) for young adult survivors of testicular cancer: a pilot randomized controlled trial of a biobehavioral intervention protocol.Hoyt, MA., Wang, AW., Ryan, SJ., et al.[2021]

References

Goal-focused Emotion-Regulation Therapy for young adult survivors of testicular cancer: Feasibility of a behavioral intervention. [2021]
Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study. [2023]
Goal-Focused Emotion-Regulation Therapy (GET) for young adult survivors of testicular cancer: a pilot randomized controlled trial of a biobehavioral intervention protocol. [2021]
A Randomized Controlled Trial of Goal-Focused Emotion-Regulation Therapy for Young Adult Survivors of Testicular Cancer: Effects on Salivary and Inflammatory Stress Markers. [2022]
The aim of psychotherapeutic intervention in cancer patients. [2019]
Goal Navigation, Approach-Oriented Coping, and Adjustment in Young Men with Testicular Cancer. [2018]